OKYO Pharma Ltd ADR is a London-based preclinical biopharmaceutical company focused on developing innovative therapies for inflammatory eye diseases and ocular pain. The company is advancing a strategically prioritized pipeline that aims to address significant unmet medical needs in the ophthalmology sector, positioning itself for growth within this specialized market. With a commitment to scientific excellence and rigorous research, OKYO Pharma is poised to enhance the quality of life for patients suffering from challenging eye conditions through its cutting-edge therapeutics. Show more

Location: 14/15 CONDUIT ST, LONDON, UNITED KINGDOM, W1S 2XJ, London, W1S 2XJ, USA | Website: https://okyopharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

89.89M

52 Wk Range

$1.01 - $3.35

Previous Close

$1.90

Open

$1.82

Volume

64,974

Day Range

$1.82 - $1.98

Enterprise Value

75.05M

Cash

4.22M

Avg Qtr Burn

-1.528M

Insider Ownership

39.37%

Institutional Own.

6.69%

Qtr Updated

06/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.